1. 928TiPATLAS: A phase II, open-label study of rucaparib in patients (pts) with locally advanced (unresectable) or metastatic urothelial carcinoma. (23rd October 2018) Authors: Chowdhury, S; Feyerabend, S; Loriot, Y; Necchi, A; Gupta, S; Josephs, D H; Rodríguez-Vida, A; Srinivas, S; Zakharia, Y; Nepert, D; Wride, K; Thomas, D; Loehr, A; Simmons, A D; Grivas, P Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗